Kirkland & Ellis has advised Lilly Asia Ventures (LAV), a leading biomedical venture capital firm, in a one and final closing of its fifth USD life…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
